Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Vrielink

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
Transfusion|July 1, 1995
Comparison of two anti-hepatitis C virus enzyme-linked immunosorbent assaysH Vrielink, H L Zaaijer, H W Reesink, et al.
Transfusion|July 1, 1994
Confirmation of hepatitis C infection: a comparison of five immunoblot assaysH L Zaaijer, H Vrielink, P J van Exel-Oehlers, et al.
Vox Sanguinis|January 1, 1995
Transmission of hepatitis C virus by anti-HCV-negative blood transfusion. Case reportH Vrielink, C L van der Poel, H W Reesink, et al.
Brain Research|December 2, 2024
Effects of hyperglycemia on neuronal network function in an in vitro model of the ischemic penumbraC J B A Kersten, T H Vrielink, H M den Hertog, et al.
Vox Sanguinis|January 1, 1995
Performance of a new third-generation anti-hepatitis C virus ELISA (Monolisa anti-HCV new antigens) in various serum panelsH Vrielink, H L Zaaijer, H W Reesink, et al.
Vox Sanguinis|January 1, 1995
Sensitivity and specificity of three third-generation anti-hepatitis C virus ELISAsH Vrielink, H L Zaaijer, H W Reesink, et al.
Transfusion|April 1, 1996
Sensitivity and specificity of four assays to detect human T-lymphotropic virus type I or type I/II antibodiesH Vrielink, H W Reesink, H L Zaaijer, et al.
Epidemiology and Infection|May 11, 2002
Prevalence of and risk factors for HIV infection in blood donors and various population subgroups in EthiopiaR E J H Sentjens, Y Sisay, H Vrielink, et al.
Transfusion|February 1, 1994
New immunoblot resolves indeterminate results for antibody to hepatitis C virusH L Zaaijer, H T Cuypers, H W Reesink, et al.
Transfusion|September 1, 1995
Reliability of the third-generation recombinant immunoblot assay for hepatitis C virusM Damen, H L Zaaijer, H T Cuypers, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Transfusion|July 1, 1995
Comparison of two anti-hepatitis C virus enzyme-linked immunosorbent assaysH Vrielink, H L Zaaijer, H W Reesink, et al.
Transfusion|July 1, 1994
Confirmation of hepatitis C infection: a comparison of five immunoblot assaysH L Zaaijer, H Vrielink, P J van Exel-Oehlers, et al.
Vox Sanguinis|January 1, 1995
Transmission of hepatitis C virus by anti-HCV-negative blood transfusion. Case reportH Vrielink, C L van der Poel, H W Reesink, et al.
Brain Research|December 2, 2024
Effects of hyperglycemia on neuronal network function in an in vitro model of the ischemic penumbraC J B A Kersten, T H Vrielink, H M den Hertog, et al.
Vox Sanguinis|January 1, 1995
Performance of a new third-generation anti-hepatitis C virus ELISA (Monolisa anti-HCV new antigens) in various serum panelsH Vrielink, H L Zaaijer, H W Reesink, et al.
Vox Sanguinis|January 1, 1995
Sensitivity and specificity of three third-generation anti-hepatitis C virus ELISAsH Vrielink, H L Zaaijer, H W Reesink, et al.
Transfusion|April 1, 1996
Sensitivity and specificity of four assays to detect human T-lymphotropic virus type I or type I/II antibodiesH Vrielink, H W Reesink, H L Zaaijer, et al.
Epidemiology and Infection|May 11, 2002
Prevalence of and risk factors for HIV infection in blood donors and various population subgroups in EthiopiaR E J H Sentjens, Y Sisay, H Vrielink, et al.
Transfusion|February 1, 1994
New immunoblot resolves indeterminate results for antibody to hepatitis C virusH L Zaaijer, H T Cuypers, H W Reesink, et al.
Transfusion|September 1, 1995
Reliability of the third-generation recombinant immunoblot assay for hepatitis C virusM Damen, H L Zaaijer, H T Cuypers, et al.
Pageof 5